Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease

Clinical trial NCT04429503 · COMPLETED

Trial details

NCT number: NCT04429503
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Diabetic Macular Edema Type 1 Diabetes Mellitus Type 2 Diabetes Mellitus

Start date: 2020-06-29
Primary completion: 2022-05-30
Enrollment: 660

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.